Improving Preterm Kidney Outcomes With Caffeine
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT07262060
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Kidney Injury
- Pre-Term
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Hours - 96 Hours
- Healthy Volunteers
- Not accepted
Interventions
- Caffeine citrate — DRUGintravenous (IV) caffeine citrate (20 milligrams per kilogram) followed by 8 milligrams per kilogram daily maintenance
- Placebo — DRUGsame volume of 0.9 percent Sodium Chloride United States Pharmacopeia (USP)
Study Details
This study is being done to see if additional caffeine citrate (20 milligrams per kilogram IV bolus) helps babies with low kidney oxygenation already being treated with caffeine citrate (20 milligrams per kilogram IV bolus on day of life (DOL) 1 followed by 8 milligrams per kilogram daily maintenance). The investigators hypothesize that additional caffeine will improve kidney oxygen levels, while not causing any brain injury, and may reduce rates of acute kidney injury compared to placebo. This study will take place in preterm babies born less than 30 weeks gestational age, with the intervention occurring between greater than 48 hours of age until DOL 14 and outcomes tracked until neonatal intensive care unit (NICU) discharge.
Key Dates
- Start date
- May 28, 2026
- Status verified
- Mar 2026
- Primary completion
- Mar 31, 2030
- Completion
- Sep 30, 2030
Study Design
- Enrollment
- 114 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm 1: Caffeine
- Placebo Comparator: Arm 2: Placebo
- No Intervention: Arm 3: Control
Primary Outcome Measure
Proportion of Participants with Improvement in Kidney Oxygenation [ Time Frame: Up to 3 hours post-intervention (Between days 1 and 17) ]
Central Contacts
- Elena Alfaro, CCRP(608) 890-0584
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UW Hospital and Clinics | Madison | Wisconsin | 53792 | - |
Find similar trials in Madison, WI
Related Studies
- KIDney Injury in Times of COVID-19 (KIDCOV)Recruiting · University of California, San Francisco · San Francisco, California
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac SurgeryPHASE4 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Motor-voice Assessment in Infants (MAMI)Recruiting · Ohio State University · Columbus, Ohio